RxDoctor Payments Data

Lisa Maier, MD

Occupational Medicine · Denver, CONPI 1134206394

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,440 of the $8,198 with a category attached, or 90.7%. Boehringer Ingelheim accounts for 94.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $7,842 and has fallen 98.6% since, to $110 in 2024. Among occupational medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,198in general payments, 2019–2025

Across 9 payments — averaging $910.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$8K
  • GSK$117
  • AstraZeneca$114
  • Amgen$114
  • Mallinckrodt Enterprises LLC$90
$127,342in research payments, 2019–2025

Across 12 payments — averaging $10,612 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mallinckrodt Enterprises LLC$89K
  • Mallinckrodt Hospital Products Inc.$38K

What the payments were for

  • Consulting fees$7,44091%
  • Travel & lodging$1402%
  • Food & beverage$6188%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim5$7,764
GSK1$117
AstraZeneca1$114
Amgen1$114
Mallinckrodt Enterprises LLC1$90

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,198 in reported general payments places this provider in the 95th percentile of 29 occupational medicine providers in Colorado.

See all occupational medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$6,344
Medicare patients
30
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Folic Acid14$107
Prednisone15$87

Paid to pharmacies, not to this prescriber.

Other occupational medicine in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →